Headline: https://links.sgx.com/1.0.0/corporate-announcements/OOBUDL3DFXOMCZ02/8fe08d288412535bc087794a04b6de473cefece79ce307ecf9be295f4350912a

Summary:

• The Annual General Meeting of Cordlife Group Limited was held on 10 June 2025, with the required quorum met.

• Shareholders approved all 10 resolutions, including adoption of FY2024 audited accounts, re-election of directors, directors’ fees for FY2025, re-appointment of auditors, and authority to issue shares.

• Notable voting outcomes (all carried with ~99.9% approval):

  • Adoption of FY2024 financial statements

  • Re-election of Chairman Zhai Lingyun and other directors including Dr. Xu Tianhong, Mr. Gao Xiang, Dr. Wang Xiaorui, Mr. Sim Sze Kuan, and Ms. Yuen Wai

  • Approval of directors’ fees up to S$400,000 for FY2025

  • Re-appointment of PKF-CAP LLP as auditors

• Management presentation highlighted FY2024 business and financial performance, strategic direction, and operational updates.

• Key shareholder concerns addressed:

  • Partial cash offer by Medeze Treasury: Company will announce its response in due course.

  • 44% of affected customers yet to accept company’s offer: Management is intensifying outreach, aided by legal advisors, with improved acceptance since mid-2023.

  • Potential liabilities beyond contracts: Contingent liabilities disclosed, but full extent remains uncertain.

  • Quality monitoring: Uses both internal metrics and external indicators such as hospital feedback and accreditation standards. Monthly reviews show steady post-incident improvement.

  • Sharing of quality indicators with MOH: Voluntary, done to ensure transparency.

  • Disclaimer audit opinion: External auditors noted FY2024 opinion was narrower, reflecting fewer uncertainties, and expect risks of future disclaimers to lessen as issues are resolved.